financetom
Business
financetom
/
Business
/
Why NextPlat Shares Are Skyrocketing Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why NextPlat Shares Are Skyrocketing Today
Apr 12, 2024 8:16 AM

NextPlat Corp ( NXPL ) shares are skyrocketing on Friday.

The company entered into a definitive business combination agreement with its majority-owned subsidiary Progressive Care Inc.

According to the business combination agreement, a NextPlat ( NXPL ) subsidiary will merge with Progressive Care, with the Merger Sub surviving as a wholly owned subsidiary of NextPlat ( NXPL ) and be renamed Progressive Care LLC.

Upon closing the merger, Progressive Care shareholders will receive newly issued, registered shares of NextPlat’s common stock. 

The exchange ratio of NextPlat ( NXPL ) shares to be issued in the business combination was calculated based upon a 20-day, volume-weighted average price of NextPlat’s Common Stock preceding execution of the business combination agreement and a value per share of common stock of Progressive Care at $2.20. 

The transaction is expected to close in the third quarter of 2024, subject to regulatory and stockholder approvals, and other customary closing conditions. 

Yesterday, NextPlat ( NXPL ) reported fiscal year 2023 revenues of $37.8 million, an increase of over 222% year over year. 

Gross margins for the full year increased significantly to 30% from 21% a year ago, primarily attributable to the healthcare operations because of the Progressive Care consolidation. 

“These developments, along with the planned launch of new products such as our Florida Sunshine brand of premium-grade vitamins and dietary supplements, represent significant opportunities for NextPlat ( NXPL ) to generate profitable new revenue streams, creating value for our clients, their customers, and our shareholders this year,” said Charles M. Fernandez, Executive Chairman and CEO of NextPlat Corp. ( NXPL )

Price Action: NXPL shares are trading higher by 34% to $2.02 on the last check Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Unlocking Thacker Pass General Motors To Contribute Combined $625 Million In Cash And Letters Of Credit To New Joint Venture With Lithium Americas
BRIEF-Unlocking Thacker Pass General Motors To Contribute Combined $625 Million In Cash And Letters Of Credit To New Joint Venture With Lithium Americas
Oct 17, 2024
Oct 16 (Reuters) - Lithium Americas Corp ( LAC ): * UNLOCKING THACKER PASS: GENERAL MOTORS TO CONTRIBUTE COMBINED $625 MILLION IN CASH AND LETTERS OF CREDIT TO NEW JOINT VENTURE WITH LITHIUM AMERICAS * LITHIUM AMERICAS CORP ( LAC ) - GM TO ACQUIRE 38% STAKE IN THACKER PASS FOR $625 MILLION * LITHIUM AMERICAS CORP ( LAC )...
Citigroup Not Under Asset Cap, Says Chief Executive Jane Nind Fraser
Citigroup Not Under Asset Cap, Says Chief Executive Jane Nind Fraser
Oct 17, 2024
07:32 AM EDT, 10/16/2024 (MT Newswires) -- Citigroup ( C ) is not under an asset cap and does not expect US regulators to impose one on the bank, Chief Executive Officer Jane Nind Fraser said during the company Tuesday earnings call. We do not have an asset cap and there are no additional measures other than what was announced...
Romanian BSOG, DN Agrar plan 15 MW biomethane production site
Romanian BSOG, DN Agrar plan 15 MW biomethane production site
Oct 17, 2024
BUCHAREST, Oct 16 (Reuters) - Romanian offshore gas producer Black Sea Oil & Gas (BSOG), controlled by private equity firm Carlyle Group LP, and leading livestock farm DN Agrar, said on Wednesday they will develop a 15 MW biomethane production plant, the first in the EU state. Romania uses a mix of gas, coal, hydro, nuclear and renewables for electricity...
Abbott slightly raises profit forecast on strong medical device sales
Abbott slightly raises profit forecast on strong medical device sales
Oct 17, 2024
Oct 16 (Reuters) - Abbott Laboratories ( ABT ) slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for quarterly earnings on strong sales of its medical devices including its glucose-monitoring products. The company now expects a full-year profit of $4.64 to $4.70 per share, with the midpoint a tad higher than that of its earlier...
Copyright 2023-2026 - www.financetom.com All Rights Reserved